Prostate-specific antigen, or PSA, is a protein made by cells in the prostate gland. A small amount normally passes into the blood, where it can be measured by a blood test and reported as a number in nanograms per milliliter (ng/mL). Both normal prostate cells and prostate cancer cells make PSA, so the level can rise when cancer is present, but it can also rise for many non-cancerous reasons. For this reason, PSA is not a simple yes-or-no test for cancer. It is one piece of information used, along with other findings, to decide whether further testing is needed and to follow a known prostate condition over time.
This article explains what the PSA test measures, what your result may mean, what can raise or lower PSA apart from cancer, and how PSA is used both to investigate a raised level and to monitor prostate cancer after diagnosis.
The reference range that applies to your result is the one printed on your laboratory report, not the typical ranges shown here. Reference ranges vary between laboratories based on the equipment used, the population tested, and individual factors such as age, sex, and pregnancy status. Always compare your result to the reference range printed on your own report, and discuss any abnormal result with your doctor.
The PSA test measures the amount of prostate-specific antigen in the blood. PSA is a protein produced by the gland cells of the prostate, and its normal job is to help keep semen in a liquid form. Because PSA is made by prostate cells whether they are healthy or cancerous, the test does not by itself tell the difference between cancer and a non-cancerous prostate condition. A higher PSA level means there is a higher chance that something is going on in the prostate, which may be cancer or may be a benign condition, and further information is needed to tell which.
PSA is measured from a small blood sample drawn from a vein, and no fasting is required. A few everyday factors can temporarily raise the level, so to avoid a misleading result, doctors often suggest waiting a couple of days after ejaculation, vigorous cycling, or a prostate examination before the blood is drawn. It is also important to tell the person ordering the test if you take a medication for an enlarged prostate, because some of these lower PSA and change how the result is interpreted. Because PSA is often followed over time, having the test done at the same laboratory helps make the trend more reliable.
There is no single PSA level that cleanly separates cancer from no cancer, which is the most important thing to understand about the result. The chance of finding prostate cancer rises gradually as PSA rises, rather than switching on at one number. The points below explain how a PSA result is generally interpreted.
Across all of these points, a PSA result guides the decision about what to do next rather than providing a diagnosis on its own. Only a biopsy, in which small samples of prostate tissue are examined under a microscope, can confirm whether cancer is present.
Many non-cancerous factors change the PSA level, which is why a raised result is interpreted carefully rather than taken as proof of cancer. Common causes of a higher PSA include benign prostatic hyperplasia (non-cancerous enlargement of the prostate), inflammation or infection of the prostate (prostatitis), a urinary tract infection, recent ejaculation, a recent prostate examination or procedure, catheter placement, and vigorous cycling. Age also raises PSA gradually as the prostate enlarges.
Some factors lower PSA. The medications used to shrink an enlarged prostate, called 5-alpha-reductase inhibitors (finasteride and dutasteride), reduce PSA by roughly half. If you take one of these, your doctor will take this into account when reading your result, often by doubling the measured value. Because so many factors can move the number in either direction, a single PSA result is always considered together with your history and, when needed, repeated before any next step.
A raised PSA usually leads to a series of steps rather than straight to a biopsy, and the aim is to work out how likely a significant prostate cancer is before deciding whether a biopsy is worthwhile. In most cases, the first step is simply to repeat the PSA, because a single elevated value often returns to normal. If the PSA remains raised, the next steps may include an MRI of the prostate and, in some situations, a secondary blood or urine test (such as free PSA, the 4Kscore, or the Prostate Health Index) that refines the estimate of risk. These tests help identify who is likely to benefit from a biopsy and who can safely avoid one.
If the overall picture still suggests a meaningful chance of cancer, a prostate biopsy is considered. During a biopsy, small samples of prostate tissue are removed and examined under a microscope. If cancer is found, the pathologist assigns a Gleason score and Grade Group, which describe how the cancer cells look and help predict how the cancer is likely to behave. You can read more in our article on prostatic adenocarcinoma, the most common type of prostate cancer. Whether to take each of these steps is a decision you make with your doctor, based on your PSA pattern, other test results, and your preferences.
Beyond investigating a raised level, PSA is one of the main tools for following prostate cancer after it has been diagnosed or treated. How it is used depends on the situation.
In each of these situations, the trend in PSA over time is what matters most, and your care team interprets it alongside your other findings to guide decisions rather than acting on a single value.